| Autor: |
Avital Licht-Murava, Samantha M. Meadows, Fernando Palaguachi, Soomin C. Song, Stephanie Jackvony, Yaron Bram, Constance Zhou, Robert E. Schwartz, Robert C. Froemke, Adam L. Orr, Anna G. Orr |
| Rok vydání: |
2023 |
| Předmět: |
|
| Zdroj: |
Science Advances. 9 |
| ISSN: |
2375-2548 |
| DOI: |
10.1126/sciadv.ade1282 |
| Popis: |
TDP-43 pathology is prevalent in dementia but the cell type-specific effects of TDP-43 are not clear and therapeutic strategies to alleviate TDP-43-linked cognitive decline are lacking. We found that patients with Alzheimer’s disease (AD) or frontotemporal dementia (FTD) have aberrant TDP-43 accumulation in hippocampal astrocytes. In mouse models, induction of widespread or hippocampus-targeted accumulation in astrocytic TDP-43 caused progressive memory loss and localized changes in antiviral gene expression. These changes were cell-autonomous and correlated with impaired astrocytic defense against infectious viruses. Among the changes, astrocytes had elevated levels of interferon-inducible chemokines and neurons had elevated levels of the corresponding chemokine receptor CXCR3 in presynaptic terminals. CXCR3 stimulation altered presynaptic function and promoted neuronal hyperexcitability, akin to the effects of astrocytic TDP-43, and blockade of CXCR3 reduced this activity. Ablation of CXCR3 also prevented TDP-43-linked memory loss. Thus, astrocytic TDP-43 dysfunction contributes to cognitive impairment through aberrant chemokine-mediated astrocytic-neuronal interactions.SummaryIn dementia, protein buildup in glia enhances chemokine signaling to synapses and impairs specific aspects of neurocognitive function. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
